The efficacy and safety of modified FOLFIRINOX as first-line chemotherapy for Chinese patients with metastatic pancreatic cancer

The efficacy and safety of modified FOLFIRINOX as first-line chemotherapy for Chinese patients with metastatic pancreatic cancer

Abstract Background Oxaliplatin, irinotecan, 5-fluorouracil, and l-leucovorin (FOLFIRINOX) has become one of the first-line treatment options for advanced pancreatic cancer (PC). However, the relatively high rate of grade 3 or 4 adverse events associated with the standard dosage of FOLFIRINOX limits...

Full description

Bibliographic Details
Main Authors: Zhi-Qiang Wang, Fei Zhang, Ting Deng, Le Zhang, Fen Feng, Feng-Hua Wang, Wei Wang, De-Shen Wang, Hui-Yan Luo, Rui-Hua Xu, Yi Ba, Yu-Hong Li
Format: Article
Language:English
Published: Wiley 2019-05-01
Series:Cancer Communications
Subjects:
Pancreatic cancer
Metastatic
Chemotherapy
FOLFIRINOX
Dose modification
First-line
Online Access:http://link.springer.com/article/10.1186/s40880-019-0367-7

Internet

http://link.springer.com/article/10.1186/s40880-019-0367-7

Similar Items